Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ImmunoMolecular Therapeutics

Request full access

Im therapeutics is working on a new platform for therapies that target the root cause of autoimmunity

Woburn, United StatesFounded 2015Health

About ImmunoMolecular Therapeutics

IM Therapeutics is a biotechnology company focused on developing personalized medicines for autoimmune diseases. The company operates in the healthcare and pharmaceutical markets, targeting conditions such as Type 1 Diabetes and Celiac Disease. Utilizing a unique approach, IM Therapeutics designs therapies that specifically block the action of HLA proteins, which are known to trigger autoimmune responses. The business model revolves around the research, development, and clinical trials of these novel therapies, with revenue generated through partnerships, grants, and eventual commercialization of successful treatments. The company serves patients suffering from autoimmune conditions, offering them innovative and targeted treatment options. IM Therapeutics is currently advancing its lead drug, IMT-002, through clinical trials and has shown promising safety data in early-phase studies.

Source: Dealroom company data

ImmunoMolecular Therapeutics in the Woburn ecosystem

Live from Dealroom

The ImmunoMolecular Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Morningside Venture Partners
  • JDRF T1D Fund
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ImmunoMolecular Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ImmunoMolecular Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.